Phio Pharmaceuticals (PHIO) Preferred Dividend Payments (2012 - 2015)
Phio Pharmaceuticals' (PHIO) quarterly Preferred Dividend Payments came in at $24000.0 in Q2 2015, down 98.02% YoY from $1.2 million in Q2 2014, and down 87.03% on a QoQ basis from $185000.0 in Q1 2015.
Phio Pharmaceuticals (PHIO) Preferred Dividend Payments (2012 - 2015) Analysis & Trends
Phio Pharmaceuticals (PHIO) has 4 years of Preferred Dividend Payments data on file, last reported at $24000.0 in Q2 2015.
- Quarterly Preferred Dividend Payments fell 98.02% year-over-year to $24000.0 in Q2 2015, while the trailing twelve-month figure through Dec 2015 was $209000.0 (down 94.94% YoY) and the FY2016 annual result came in at $2.1 million, up 892.82% from the prior year.
- Preferred Dividend Payments eased to $24000.0 in Q2 2015, from $185000.0 in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $10.6 million in Q2 2012 to a low of $24000.0 in Q2 2015.
- A 4-year average of $2.0 million and a median of $1.2 million in 2013 frame the typical range for Preferred Dividend Payments.
- Annual changes were most pronounced in 2013 — Preferred Dividend Payments jumped 32.57% — and 2015, when it slumped 98.02%.
- Tracing PHIO's Preferred Dividend Payments over 4 years: stood at $918000.0 in 2012, then jumped by 32.57% to $1.2 million in 2013, then sank by 62.04% to $462000.0 in 2014, then tumbled by 94.81% to $24000.0 in 2015.
- The last three Preferred Dividend Payments figures came in at $24000.0 (Q2 2015), $185000.0 (Q1 2015), and $462000.0 (Q4 2014), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Phio Pharmaceuticals | 13.77 Mn | 13.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 24,000.00 |
| Mar 31, 2015 | 185,000.00 |
| Dec 31, 2014 | 462,000.00 |
| Sep 30, 2014 | 700,000.00 |
| Jun 30, 2014 | 1.21 Mn |
| Mar 31, 2014 | 1.76 Mn |
| Dec 31, 2013 | 1.22 Mn |
| Sep 30, 2013 | 1.45 Mn |
| Jun 30, 2013 | 2.40 Mn |
| Mar 31, 2013 | 3.55 Mn |
| Dec 31, 2012 | 918,000.00 |
| Sep 30, 2012 | 1.28 Mn |
| Jun 30, 2012 | 10.62 Mn |